Confluence graph
RIGLRigel Pharmaceuticals Inc
Mixed signals
Do the independent disclosure sources agree on RIGL? This graph shows where institutional funds (13F), corporate insiders (Form 4), and US House members (STOCK Act) are all buying or selling the same name — the cross-source corroboration that's hardest to fake. Green = buying, red = selling.
SEC EDGAR 13F + Form 4 + US House STOCK Act
Your agent can pull this verdict — the cross-source join + rotation context.
{ }get_ticker_confluence · API & MCPSignals by source
Insiders & Congress: last 180 days · funds: latest 13F
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Latest quarterly filings | 51 | 33 | — |
Insiders Form 4 open-market | 0 | 1 | -$145K |
US House STOCK Act trades | 0 | 0 | $0 |
Sector rotation
RIGL is in Health Care, which smart money is rotating INTO
+$50.6B
Capital Rotation reports where institutional capital DISCLOSED rotating, as of the latest public SEC 13F filings. It is DATA, NOT investment advice, a recommendation, or a prediction. Filings lag ~45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.